Riskpilot← Back to searchSign inGet full accessHEMISPHERIAN AS
ASActiveOrg 925333409Lørenveien 73A, 0585 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20205 employees
Revenue 2024
NOK 269K
+343% vs 2023
EBITDA margin
-7323.7%
-1% vs 2023
Equity ratio
-23.1%
Financial strength
Net profit 2024
NOK -21,5M
-11% vs 2023
| Revenue | NOK 269K | +343% |
| EBITDA | NOK -19,7M | -1% |
| Net profit | NOK -21,5M | -11% |
| Total assets | NOK 25,7M | +24% |
| Equity | NOK -5,9M | -138% |
| Employees | 5 | — |
Legal name
HEMISPHERIAN AS
Org number
925333409
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
13. juli 2020
Share capital
NOK 343 434
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Forskning og utvikling av legemidler, konsulenttjenester innenfor software og beregningsbiologi, selv eller gjennom investeringer og eierskap i andre selskaper.
Address
Lørenveien 73A, 0585 Oslo
Phone
+4740603455
Email
info@hemispherian.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 828 | 81 | 54 | 61 | 269 |
| Staff expenses | −883 | −1 291 | −1 346 | −4 304 | −3 918 |
| EBITDA | −599 | −3 339 | −8 019 | −19 512 | −19 725 |
| Depreciation & amort. | −17 | −19 | −56 | −260 | −439 |
| EBIT | −616 | −3 358 | −8 075 | −19 772 | −20 164 |
| Net financials | −3 | −17 | 103 | 425 | −1 365 |
| Profit before tax | −620 | −3 375 | −7 972 | −19 346 | −21 529 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −620 | −3 375 | −7 972 | −19 346 | −21 529 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 963 | 3 205 | 49 673 | 20 678 | 25 674 |
| Equity | 4 190 | 1 065 | 34 941 | 15 595 | −5 933 |
| Long-term debt | 0 | 0 | 0 | 0 | 26 426 |
| Short-term debt | 1 772 | 2 140 | 14 731 | 5 083 | 5 181 |
| Total debt | 1 772 | 2 140 | 14 731 | 5 083 | 31 607 |
EBITDA margin
-7323.7%
This company
15.8%
Market median
-46453% vs market
20202024
Equity ratio
-23.1%
This company
38.2%
Market median
-160% vs market
20202024
Return on equity
-2152918100.0%
This company
18.4%
Market median
-11700641948% vs market
20202024
Net profit margin
-7993.5%
This company
8.1%
Market median
-98785% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
5.33×
This company
0.62×
Market median
-760% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BG Observer | Observer | 2022 | — | — |
ZA Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
FV Observer | Observer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Kistefos As | Company | 16.4% | 16.4% | 2024 |
Meneldor At Coperatie Iii U.A | Company | 14.3% | 14.3% | 2024 |
| Individual | 14.3% | 14.3% | 2022 | |
Meneldor Nhs Cooperatie I U.A | Company | 13.4% | 13.4% | 2024 |
Janda As | Company | 8.6% | 8.6% | 2024 |
Albisser As | Company | 8.6% | 8.6% | 2024 |
Prikrylova As | Company | 4.8% | 4.8% | 2024 |
Paacs Invest As | Company | 4.3% | 4.3% | 2024 |
Investinor Indirekte Ii As | Company | 3.7% | 3.7% | 2024 |
Gilbert Gerber | Company | 3.7% | 3.7% | 2024 |
Nectera As | Company | 2.1% | 2.1% | 2024 |
Lee W Berryman | Company | 1.9% | 1.9% | 2024 |
Kvantia As | Company | 1.8% | 1.8% | 2024 |
Ojt Holding As | Company | 1.6% | 1.6% | 2024 |
Storstad As | Company | 1.6% | 1.6% | 2024 |
Livermore Invest As | Company | 1.6% | 1.6% | 2024 |
| Individual | 1.3% | 1.3% | 2024 | |
Mark Robertson | Company | 1.3% | 1.3% | 2023 |
Lie Holding As | Company | 1.3% | 1.3% | 2024 |
Strigen As | Company | 1.1% | 1.1% | 2024 |
Acier As | Company | 1.1% | 1.1% | 2024 |
Stoko As | Company | 1.0% | 1.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HEMISPHERIAN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Birgitte Gangmark Villmo | Observer | 0 companies |
| Zeno Albisser | Chief Executive Officer | 0 companies |
| Frans Van Dalen | Observer | 0 companies |
| Paul Govert Michael Lelieveld | Chairman | 0 companies |
| Wolfram Thomas Eichner | Board of Directors | 0 companies |
| Dallas Christian Hack | Board of Directors | 0 companies |
| Paul Govert Michael Leileveld | Board of Directors | 0 companies |
| Cecilie Stenstadvold Sverdrup | Board of Directors | 0 companies |
| Frode Vartdal | Board of Directors | 0 companies |
| Steven John Powell | Chairman | 0 companies |
| Masha Paule Nathalie Legris Strømme | Chairman | 0 companies |